Abstract
Using synthetic peptide or recombinant protein as immunising antigens we have produced monoclonal antibodies and polyclonal antisera directed against targets of particular interest in leukaemia diagnosis. In this way we have prepared reagents which recognise all T or all B lymphocytes in routinely fixed paraffin sections which are unique in this respect. We have also produced monoclonal antibodies to molecules potentially involved in specific neoplastic transformations, implicated by virtue of the involvement of their genes in chromosomal defects in these neoplasms. In particular, we have produced antibodies recognising bcl-2, involved in follicular lymphoma, tal-1, involved in T-cell acute leukaemias and HRX involved in a variety of hematologic disorders. The application of these reagents to diagnosis has so far proved useful. In addition their use outside the field of leukaemia diagnosis has proved to be even more important in some cases.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Begley, C. G., Aplan, P. D., Davey, M. P., Nakahara, K., Tchorz, K., Kurtzberg, J., Hershfleld, M. S., Haynes, B. F., Cohen, D. I., Waldmann, T. A.,el al. (1989) Chromosomal translocation in a human leukemic stem-cell line disrupts the T-cell antigen receptor delta-chain diversity region and results in a previously unreported fusion transcript.Proc. Natl. Acad. Sci. USA 86:2031–5.
Bernard, O. A. and Berger, R. (1995) Molecular basis of 11q23 rearrangements in hematopoietic malignant proliferations.Genes, Chromosomes & Cancer,13:75–85.
Chetty, R., Pulford, K., Jones, M., Mathieu-Mahul, D., Close, P., Hussein, S., Pallesen, G., Ralfkier, E., Stein, H., Gatter, K. and Mason, D. Y. (1995) SCL/Tal-1 expression in T-acute lymphoblastic leukemia: An immunohistochemical and genotypic study.Human Pathology,26:994–998.
Hockenbery, D., Nunez, G., Milliman, C., Schreiber, R. D. and Korsmeyer, S. J. (1990) Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death.Nature,348:334–6.
Mason, D. Y., Cordell, J., Brown, M., Pallesen, G., Ralfkiaer, E., Rothbard, J., Crumpton, M. and Gatter, K. C. (1989) Detection of T cells in parafin wax embedded tissue using antibodies against a peptide sequence from the CD3 antigen.J. Clin. Pathol. 42:1194–200.
Mason, D. Y. and Gatter, K. C. (1985) Immunohistochemistry in histological diagnosis.Recent Advances In Histopthology,12:263–283.
Ngan, B. Y., Chen, L. Z., Weiss, L. M., Warnke, R. A. and Cleary, M. L. (1988) Expression in non-Hodgkin's lymphoma of the bcl-2 protein associated with the t(14; 18) chromosomal translocation.N. Engl. J. Med. 318:1638–44.
Pezzella, F., Tse, A. G., Cordell, J. L., Pulford, K. A., Gatter, K. C. and Mason D. Y. (1990). Expression of the bcl-2 oncogene protein is not specific for the 14; 18 chromosomal translocation.Am. J. Pathol. 137:225–32.
Pezzella, F., Turley, H., Kuzu, I., Tungekar, M. F., Dunnill, M. S., Pierce, C. B., Harris, A., Gatter, K. C. and Mason, D. Y. (1993) bcl-2 protein in non-small-cell lung carcinoma.N. Engl. J. Med. 329:690–4.
Pulford, K., Lecointe, N., Leroy, V. K., Jones, M., Mathieu, M. D. and Mason, D. Y. (1995) Expression of TAL-1 proteins in human tissues.Blood,85:675–84.
Schlossman, S. F., Cordell, J., Brown, M., Pallesen, G., Ralfkiaer, E., Rothbard, J., Crumpton, M. and Gatter, K. C. (1995). Leukocyte Typing V.
Yunis, J. J., Mayer, M. G., Arnesen, M. A., Aeppli, D. P., Oken, M. M. and Frizzera, G., (1989) bcl-2 and other genomic alterations in the prognosis of large-cell lymphoma.N. Engl. J. Med.,320:1047–54.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Micklem, K.J. Novel leukaemia markers. Biosci Rep 15, 463–468 (1995). https://doi.org/10.1007/BF01204349
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01204349